← Back to VOLUME 13, ISSUE 11, NOVEMBER 2026
This work is licensed under a Creative Commons Attribution 4.0 International License.
Artificial Intelligence in Pharmacognosy: Transforming Natural Product Drug Discovery
Ms.SrushtI Maske, Ms Laxmi Maske, Ms Sayali Nanaware, Prof.Dr Nitin Waghmode
👁 4 views📥 3 downloads
Abstract: Natural products contain chemical diversity, but their discovery is impeded by complex mixtures, repeated discoveries, vague and uncertain therapeutic targets, and validation. Artificial intelligence (AI) can link metabolomics, genomics, and other molecular data and streamline the pharmacognosy workflow. This narrative review summarizes the papers published between 2020 to 2025 on chemical classification, dereplication, genome mining, molecular property prediction, docking, and the assessment of absorption, distribution, metabolism, excretion and toxicity (ADMET). AI, along with deep learning and other emerging generative models, can predict structures, annotate compounds, and classify them based on their expected activities. Reassuringly, some structures have been annotated with high confidence, but deep learning models remain untested. Thus, in the case of AI, main reliance should be placed on experimental validation.
Keywords: artificial intelligence; pharmacognosy; natural products; machine learning; drug discovery; phytochemistry; deep learning.
Keywords: artificial intelligence; pharmacognosy; natural products; machine learning; drug discovery; phytochemistry; deep learning.
How to Cite:
[1] Ms.SrushtI Maske, Ms Laxmi Maske, Ms Sayali Nanaware, Prof.Dr Nitin Waghmode, “Artificial Intelligence in Pharmacognosy: Transforming Natural Product Drug Discovery,” International Advanced Research Journal in Science, Engineering and Technology (IARJSET), DOI: 10.17148/IARJSET.2026.131122
